NYXH
Price
$6.22
Change
-$0.58 (-8.53%)
Updated
Aug 15 closing price
Capitalization
246.88M
Earnings call today
TMO
Price
$489.01
Change
+$3.97 (+0.82%)
Updated
Aug 15 closing price
Capitalization
184.66B
65 days until earnings call
Interact to see
Advertisement

NYXH vs TMO

Header iconNYXH vs TMO Comparison
Open Charts NYXH vs TMOBanner chart's image
Nyxoah SA
Price$6.22
Change-$0.58 (-8.53%)
Volume$266.42K
Capitalization246.88M
Thermo Fisher Scientific
Price$489.01
Change+$3.97 (+0.82%)
Volume$2.46M
Capitalization184.66B
NYXH vs TMO Comparison Chart in %
Loading...
NYXH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TMO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
NYXH vs. TMO commentary
Aug 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NYXH is a Buy and TMO is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 18, 2025
Stock price -- (NYXH: $6.22 vs. TMO: $489.39)
Brand notoriety: NYXH and TMO are both not notable
NYXH represents the Pharmaceuticals: Other, while TMO is part of the Medical Specialties industry
Current volume relative to the 65-day Moving Average: NYXH: 322% vs. TMO: 88%
Market capitalization -- NYXH: $246.88M vs. TMO: $184.66B
NYXH [@Pharmaceuticals: Other] is valued at $246.88M. TMO’s [@Medical Specialties] market capitalization is $184.66B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $172.16B to $0. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $11.04B. The average market capitalization across the [@Medical Specialties] industry is $10.48B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NYXH’s FA Score shows that 0 FA rating(s) are green whileTMO’s FA Score has 0 green FA rating(s).

  • NYXH’s FA Score: 0 green, 5 red.
  • TMO’s FA Score: 0 green, 5 red.
According to our system of comparison, TMO is a better buy in the long-term than NYXH.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NYXH’s TA Score shows that 4 TA indicator(s) are bullish while TMO’s TA Score has 5 bullish TA indicator(s).

  • NYXH’s TA Score: 4 bullish, 5 bearish.
  • TMO’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, TMO is a better buy in the short-term than NYXH.

Price Growth

NYXH (@Pharmaceuticals: Other) experienced а -16.17% price change this week, while TMO (@Medical Specialties) price change was +6.22% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +0.19%. For the same industry, the average monthly price growth was -0.65%, and the average quarterly price growth was +3.82%.

The average weekly price growth across all stocks in the @Medical Specialties industry was +2.98%. For the same industry, the average monthly price growth was +4.68%, and the average quarterly price growth was +0.72%.

Reported Earning Dates

NYXH is expected to report earnings on Aug 18, 2025.

TMO is expected to report earnings on Oct 22, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+0.19% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

@Medical Specialties (+2.98% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TMO($185B) has a higher market cap than NYXH($247M). TMO YTD gains are higher at: -5.751 vs. NYXH (-22.250). TMO has higher annual earnings (EBITDA): 11.3B vs. NYXH (-64.3M). TMO has more cash in the bank: 6.39B vs. NYXH (63M). NYXH has less debt than TMO: NYXH (22.1M) vs TMO (35.2B). TMO has higher revenues than NYXH: TMO (43.2B) vs NYXH (4.36M).
NYXHTMONYXH / TMO
Capitalization247M185B0%
EBITDA-64.3M11.3B-1%
Gain YTD-22.250-5.751387%
P/E RatioN/A28.28-
Revenue4.36M43.2B0%
Total Cash63M6.39B1%
Total Debt22.1M35.2B0%
FUNDAMENTALS RATINGS
TMO: Fundamental Ratings
TMO
OUTLOOK RATING
1..100
23
VALUATION
overvalued / fair valued / undervalued
1..100
73
Overvalued
PROFIT vs RISK RATING
1..100
73
SMR RATING
1..100
58
PRICE GROWTH RATING
1..100
49
P/E GROWTH RATING
1..100
82
SEASONALITY SCORE
1..100
3

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
NYXHTMO
RSI
ODDS (%)
Bullish Trend 4 days ago
88%
Bearish Trend 4 days ago
54%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
69%
Bearish Trend 4 days ago
57%
Momentum
ODDS (%)
Bearish Trend 4 days ago
88%
Bullish Trend 4 days ago
62%
MACD
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
74%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
87%
Bullish Trend 4 days ago
62%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
86%
Bullish Trend 4 days ago
61%
Advances
ODDS (%)
N/A
Bullish Trend 4 days ago
60%
Declines
ODDS (%)
Bearish Trend 6 days ago
89%
Bearish Trend 13 days ago
63%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
80%
Bearish Trend 4 days ago
56%
Aroon
ODDS (%)
Bullish Trend 6 days ago
71%
Bullish Trend 4 days ago
55%
View a ticker or compare two or three
Interact to see
Advertisement
NYXH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TMO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
APT4.610.05
+1.10%
Alpha Pro Tech Ltd
GAL.X1.426427-0.009506
-0.66%
Galatasaray Fan Token cryptocurrency
R180.02-2.09
-1.15%
Ryder System
HROW38.82-1.19
-2.97%
Harrow
GAMB8.61-1.77
-17.05%
Gambling.com Group Limited

NYXH and

Correlation & Price change

A.I.dvisor indicates that over the last year, NYXH has been loosely correlated with LFTSF. These tickers have moved in lockstep 33% of the time. This A.I.-generated data suggests there is some statistical probability that if NYXH jumps, then LFTSF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NYXH
1D Price
Change %
NYXH100%
-8.53%
LFTSF - NYXH
33%
Loosely correlated
N/A
PROF - NYXH
25%
Poorly correlated
-23.29%
NMTC - NYXH
24%
Poorly correlated
-1.23%
TMO - NYXH
23%
Poorly correlated
+0.90%
FEMY - NYXH
23%
Poorly correlated
-7.33%
More

TMO and

Correlation & Price change

A.I.dvisor indicates that over the last year, TMO has been closely correlated with DHR. These tickers have moved in lockstep 79% of the time. This A.I.-generated data suggests there is a high statistical probability that if TMO jumps, then DHR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TMO
1D Price
Change %
TMO100%
+0.90%
DHR - TMO
79%
Closely correlated
+0.34%
A - TMO
79%
Closely correlated
+0.28%
MTD - TMO
76%
Closely correlated
-0.10%
RVTY - TMO
74%
Closely correlated
+1.49%
BRKR - TMO
69%
Closely correlated
-0.36%
More